Back to Agenda
Session 7: Decentralized, Virtual and Remote Trials
Session Chair(s)
Scott Askin, MSc
Global Program Regulatory Director, Novartis Pharma AG, Switzerland
Francesca Cerreta, PharmD, MPharm, MS
Principal Scientific Officer, European Medicines Agency, Netherlands
Session 6: Decentralized, virtual and remote trials
Speaker(s)
Introduction: Current Regulation and Guidance
Scott Askin, MSc
Global Program Regulatory Director, Novartis Pharma AG, Switzerland
TeleMedicine: Setting the Standards in Remote Trials?
Andy Fischer
President, ISfTeH & CEO, Medgate, Switzerland
FDA’s Perspective on Innovative Clinical Trial Designs using Digital Tools
M. Khair ElZarrad, PhD, MPH
Vice President, Regulatory Policy, BridgeBio, United States
Decentralized, virtual and remote trials – How is the EU enabling success
Francesca Cerreta, PharmD, MPharm, MS
Principal Scientific Officer, European Medicines Agency, Netherlands
Have an account?